Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

150 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
New anticancer agents.
Weiss GR, Burris HA 3rd, Eckardt JR, Fields S, O'Rourke T, Rodriguez GI, Rothenberg ML. Weiss GR, et al. Among authors: rothenberg ml. Cancer Chemother Biol Response Modif. 1994;15:130-51. Cancer Chemother Biol Response Modif. 1994. PMID: 7779583 Review. No abstract available.
Preclinical and phase I trials of topoisomerase I inhibitors.
Von Hoff DD, Burris HA 3rd, Eckardt J, Rothenberg M, Fields SM, Chen SF, Kuhn JG. Von Hoff DD, et al. Cancer Chemother Pharmacol. 1994;34 Suppl:S41-5. doi: 10.1007/BF00684862. Cancer Chemother Pharmacol. 1994. PMID: 8070026 Clinical Trial.
Phase I and pharmacokinetic trial of weekly CPT-11.
Rothenberg ML, Kuhn JG, Burris HA 3rd, Nelson J, Eckardt JR, Tristan-Morales M, Hilsenbeck SG, Weiss GR, Smith LS, Rodriguez GI, et al. Rothenberg ML, et al. J Clin Oncol. 1993 Nov;11(11):2194-204. doi: 10.1200/JCO.1993.11.11.2194. J Clin Oncol. 1993. PMID: 8229134 Clinical Trial.
New anticancer agents.
Weiss GR, Burris HA, Eckardt JR, Fields S, Johnson R, O'Rourke T, Rodriguez GI, Rothenberg ML, Wall J. Weiss GR, et al. Among authors: rothenberg ml. Cancer Chemother Biol Response Modif. 1993;14:118-28. Cancer Chemother Biol Response Modif. 1993. PMID: 8312101 Review. No abstract available.
New anticancer agents.
Weiss GR, Burris 3rd HA, Eckardt JR, Eckhardt SG, Fields SM, O'Rourke T, Rodriguez GI, Rothenberg ML, Valley AJ. Weiss GR, et al. Among authors: rothenberg ml. Cancer Chemother Biol Response Modif. 1996;16:132-67. Cancer Chemother Biol Response Modif. 1996. PMID: 8639381 Review. No abstract available.
A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancer.
Rothenberg ML, Moore MJ, Cripps MC, Andersen JS, Portenoy RK, Burris HA 3rd, Green MR, Tarassoff PG, Brown TD, Casper ES, Storniolo AM, Von Hoff DD. Rothenberg ML, et al. Ann Oncol. 1996 Apr;7(4):347-53. doi: 10.1093/oxfordjournals.annonc.a010600. Ann Oncol. 1996. PMID: 8805925 Free article. Clinical Trial.
150 results